Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours

Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), using gadopentetate dimeglumine, was used to monitor acute effects on tumour vascular permeability following inhibition of vascular endothelial growth factor-A (VEGF-A) signal transduction. Mice bearing PC-3 human prostate adenocarcinom...

Descripción completa

Detalles Bibliográficos
Autores principales: Checkley, D, Tessier, J J, Kendrew, J, Waterton, J C, Wedge, S R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394431/
https://www.ncbi.nlm.nih.gov/pubmed/14612898
http://dx.doi.org/10.1038/sj.bjc.6601386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394431/
https://www.ncbi.nlm.nih.gov/pubmed/14612898
http://dx.doi.org/10.1038/sj.bjc.6601386

Ejemplares similares